Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte

Detalhes bibliográficos
Autor(a) principal: Medeiros, Amira Rose Costa
Data de Publicação: 2017
Tipo de documento: Tese
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da UFPB
Texto Completo: https://repositorio.ufpb.br/jspui/handle/tede/8998
Resumo: Food insecurity (FI) reaches 22.6% of the Brazilian population, but its prevalence and consequence in people living with HIV/Aids (PLWHA) are little known in Brazil. The consequences were studied in PLWHA, considering its effect on clinical morbidity associated with HIV/Aids, on the metabolic changes of HIV Lipodistrophic Syndrome, cardiovascular risk (CVR) and adherence to treatment. A cohort of 400 PLWHA accompanied on a reference service in the State of Paraíba, between March 2015 to May 2016, which were classified in two groups for exposure to FI, obtained by Brazilian Range of food insecurity and accompanied by a year to evaluate the outcomes. Described if the frequencies of socio-demographic variables, clinical, laboratory and the CVR; through its association with FI, using the Chi square and Mann-Whitney tests. Instrument devised to assess adherence to antiretroviral therapy (ART). Using Kaplan-Meier estimators and Nelson-Aalen to estimate survival. The Logrank test compared the curves for variable, and we used Cox regression model to estimate the risk associated with each outcome. Devised decision tree model to identify individuals with viral load (VL) detectable. The sample was characterized by most male (61.5%), race/color brown (54.8%), mean and median age of 44 years, 57.1% education; incomplete elementary school, 48.5% were retired, 32.8% with per capita incomes between 1/3 to 1/2 minimum wage in force. The average time to diagnosis was 7.8 years and use of HAART was 6.9 years. The prevalence of was 70.7% 399 of PLWHA, being higher in households with children under 18 years old, and FI afflicted 19.5 percent of these people. Moderate or severe FI (MFI/SFI) was associated with female sex, race/color; white, low education, low income per capita, being unemployed, not being adherent to HAART and have undetectable VL. There was no difference between the groups for levels of hemoglobin, hematocrit, serum proteins, glucose, lipid profile and body mass index. Individuals in MFI/SFI were more smokers, sedentary and with higher levels of ultra sensitive protein C. The CVR was classified as high 7.9, 40.7% of PLWHA and when used, respectively, the Framingham risk score and the Overall risk score, and not related to MFI/SFI. The Accession score 42 presented 63% of accuracy to detect the PLWHA with undetectable VL and 58.5 percent ranked as adherents. Poor adherence to HAART increased by 1.6 times the risk for care in the hospital, at 1.7 times the risk to introduce infectious diseases associated with HIV/Aids and immunodeficiencies in 1.9 times the risk to submit to undetectable VL after 12 months. The MFI/SFI was associated with worse survival to seek care at the hospital, introduce infectious diseases associated with HIV/Aids immunodeficiency and have CD4 count less than 350 cells/mm3, during the following 12 months. Individuals adhering to treatment in food safety or FI take had better survival for present undetectable VL. Being in MFI/SFI increased by 1.7 times the risk to seek care at the hospital, 1.9 times the risk for infectious disease associated with HIV/Aids immunodeficiency and 1.7 times the risk for HIV/Aids related diseases not associated with immunodeficiency, during the following 12 months. At the end of this period the VL was undetectable in 76.7 percent of 322 individuals, each with their own new tests. The evaluation of VL, CD4 cell count and treatment adherence was able to predict correctly 80.0% of PLWHA regarding detectable after 12 months VL from rules obtained by the decision tree model. The FI is a stressor that worsens the clinical evolution of PLWHA in the following 12 months, such as vulnerability to be better investigated and valued for the effective control of the Aids epidemic.
id UFPB_127da44b4cbd194902fdb8c7e1b75de1
oai_identifier_str oai:repositorio.ufpb.br:tede/8998
network_acronym_str UFPB
network_name_str Biblioteca Digital de Teses e Dissertações da UFPB
repository_id_str
spelling Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorteInsegurança alimentarEstudo CoorteFood insecurityAcquired Immune Deficiency Syndrome - AIDSCohort StudyCIENCIAS DA SAUDE::SAUDE COLETIVAFood insecurity (FI) reaches 22.6% of the Brazilian population, but its prevalence and consequence in people living with HIV/Aids (PLWHA) are little known in Brazil. The consequences were studied in PLWHA, considering its effect on clinical morbidity associated with HIV/Aids, on the metabolic changes of HIV Lipodistrophic Syndrome, cardiovascular risk (CVR) and adherence to treatment. A cohort of 400 PLWHA accompanied on a reference service in the State of Paraíba, between March 2015 to May 2016, which were classified in two groups for exposure to FI, obtained by Brazilian Range of food insecurity and accompanied by a year to evaluate the outcomes. Described if the frequencies of socio-demographic variables, clinical, laboratory and the CVR; through its association with FI, using the Chi square and Mann-Whitney tests. Instrument devised to assess adherence to antiretroviral therapy (ART). Using Kaplan-Meier estimators and Nelson-Aalen to estimate survival. The Logrank test compared the curves for variable, and we used Cox regression model to estimate the risk associated with each outcome. Devised decision tree model to identify individuals with viral load (VL) detectable. The sample was characterized by most male (61.5%), race/color brown (54.8%), mean and median age of 44 years, 57.1% education; incomplete elementary school, 48.5% were retired, 32.8% with per capita incomes between 1/3 to 1/2 minimum wage in force. The average time to diagnosis was 7.8 years and use of HAART was 6.9 years. The prevalence of was 70.7% 399 of PLWHA, being higher in households with children under 18 years old, and FI afflicted 19.5 percent of these people. Moderate or severe FI (MFI/SFI) was associated with female sex, race/color; white, low education, low income per capita, being unemployed, not being adherent to HAART and have undetectable VL. There was no difference between the groups for levels of hemoglobin, hematocrit, serum proteins, glucose, lipid profile and body mass index. Individuals in MFI/SFI were more smokers, sedentary and with higher levels of ultra sensitive protein C. The CVR was classified as high 7.9, 40.7% of PLWHA and when used, respectively, the Framingham risk score and the Overall risk score, and not related to MFI/SFI. The Accession score 42 presented 63% of accuracy to detect the PLWHA with undetectable VL and 58.5 percent ranked as adherents. Poor adherence to HAART increased by 1.6 times the risk for care in the hospital, at 1.7 times the risk to introduce infectious diseases associated with HIV/Aids and immunodeficiencies in 1.9 times the risk to submit to undetectable VL after 12 months. The MFI/SFI was associated with worse survival to seek care at the hospital, introduce infectious diseases associated with HIV/Aids immunodeficiency and have CD4 count less than 350 cells/mm3, during the following 12 months. Individuals adhering to treatment in food safety or FI take had better survival for present undetectable VL. Being in MFI/SFI increased by 1.7 times the risk to seek care at the hospital, 1.9 times the risk for infectious disease associated with HIV/Aids immunodeficiency and 1.7 times the risk for HIV/Aids related diseases not associated with immunodeficiency, during the following 12 months. At the end of this period the VL was undetectable in 76.7 percent of 322 individuals, each with their own new tests. The evaluation of VL, CD4 cell count and treatment adherence was able to predict correctly 80.0% of PLWHA regarding detectable after 12 months VL from rules obtained by the decision tree model. The FI is a stressor that worsens the clinical evolution of PLWHA in the following 12 months, such as vulnerability to be better investigated and valued for the effective control of the Aids epidemic.A insegurança alimentar (IA) atinge 22,6% da população brasileira, porém sua prevalência e consequência em pessoas vivendo com HIV/Aids (PVHA) são pouco conhecidas no Brasil. Estudaram-se as consequências da IA em PVHA, considerando seu efeito sobre a morbidade clínica associada ao HIV/Aids, sobre alterações metabólicas da Síndrome Lipodistrófica do HIV, o risco cardiovascular (RCV) e a adesão ao tratamento. Realizou-se uma coorte de 400 PVHA acompanhadas em serviço de referência no Estado da Paraíba, entre março de 2015 a maio de 2016, que foram classificadas em dois grupos quanto à exposição à IA, obtida pela Escala Brasileira de Insegurança Alimentar e acompanhadas por um ano para avaliação dos desfechos. Descreveram-se as frequências das variáveis sociodemográficas, clínicas, laboratoriais e o RCV; com sua associação com IA, utilizando os testes quiquadrado e Mann-Whitney. Elaborou-se instrumento para avaliar a adesão à terapia antirretroviral (TARV). Utilizaram-se os estimadores de Kaplan-Meier e Nelson-Aalen para estimar a sobrevivência. O teste Logrank comparou as curvas por variável, e utilizou-se modelo de regressão de Cox para estimar o risco associado a cada desfecho. Elaborou-se modelo de árvore de decisão para identificar os indivíduos com carga viral (CV) detectável. A amostra caracterizou-se por maioria do sexo masculino (61,5%), raça/cor parda (54,8%), média e mediana da idade de 44 anos, 57,1% com escolaridade até ensino fundamental incompleto, 48,5% eram aposentados, 32,8% com renda per capita entre 1/3 a 1/2 salário mínimo vigente. O tempo médio de diagnóstico foi de 7,8 anos e de uso de TARV foi de 6,9 anos. A prevalência de IA foi de 70,7% em 399 PVHA, sendo maior nos domicílios com menores de 18 anos, e a IA grave acometeu 19,5% dessas pessoas. A IA moderada ou grave (IAMo/IAG) esteve associada ao sexo feminino, à raça/cor não branca, à baixa escolaridade, baixa renda per capita, estar desempregado, não ser aderente à TARV e ter CV detectável. Não houve diferença entre os grupos para níveis de hemoglobina, hematócrito, proteínas séricas, glicemia, perfil lipídico e índice de massa corporal. Indivíduos em IAMo/IAG eram mais tabagistas, sedentários e com maiores níveis de Proteína C ultrassensível. O RCV foi classificado como alto em 7,9 e 40,7% das PVHA quando se utilizaram, respectivamente, o Escore de Risco de Framingham e o Escore de Risco Global, e não se relacionou com IAMo/IAG. O Escore de Adesão 42 apresentou acurácia de 63% para detectar as PVHA com CV detectável e classificou 58,5% como aderentes. A má adesão à TARV aumentou em 1,6 vezes o risco para atendimento no hospital dia, em 1,7 vezes o risco para apresentar doença infecciosa associada à imunodeficiência do HIV/Aids e em 1,9 vezes o risco para apresentar CV detectável no seguimento de 12 meses. A IAMo/IAG esteve associada com pior sobrevida para procurar atendimento no hospital dia, apresentar doença infecciosa associada à imunodeficiência do HIV/Aids e ter contagem de CD4 menor que 350 células/mm3, durante o seguimento de 12 meses. Indivíduos aderentes ao tratamento em segurança alimentar ou IA leve tiveram melhor sobrevida para apresentar CV detectável. Estar em IAMo/IAG aumentou em 1,7 vezes o risco para procurar atendimento no hospital dia, em 1,9 vezes o risco para doença infecciosa associada à imunodeficiência do HIV/Aids e em 1,7 vezes o risco para doença relacionada ao HIV/Aids não associada à imunodeficiência, durante o seguimento de 12 meses. Ao final deste período a CV estava indetectável em 76,7% dos 322 indivíduos, que dispunham de novos exames. A avaliação da CV, contagem de células CD4 e adesão ao tratamento foi capaz de predizer corretamente 80,0% das PVHA quanto à CV detectável após 12 meses a partir de regras obtidas pelo modelo de árvore de decisão. A IA é um estressor que piora a evolução clínica de PVHA no seguimento de 12 meses, destacando-se como ponto de vulnerabilidade a ser melhor investigado e valorizado para o controle efetivo da epidemia de Aids.Universidade Federal da ParaíbaBrasilCiências Exatas e da SaúdePrograma de Pós-Graduação em Modelos de Decisão e SaúdeUFPBVianna, Rodrigo Pinheiro de Toledohttp://lattes.cnpq.br/3915051035089861Marcos de Moraes, Roneihttp://lattes.cnpq.br/7925449690046513Medeiros, Amira Rose Costa2017-06-16T13:14:49Z2018-07-21T00:21:57Z2018-07-21T00:21:57Z2017-02-16info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfMEDEIROS, Amira Rose Costa. Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte. 2017. 261 f. Tese (Doutorado em Modelos de Decisão e Saúde) - Universidade Federal da Paraíba, João Pessoa, 2017https://repositorio.ufpb.br/jspui/handle/tede/8998porinfo:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UFPBinstname:Universidade Federal da Paraíba (UFPB)instacron:UFPB2018-09-06T00:47:39Zoai:repositorio.ufpb.br:tede/8998Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufpb.br/PUBhttp://tede.biblioteca.ufpb.br:8080/oai/requestdiretoria@ufpb.br|| diretoria@ufpb.bropendoar:2018-09-06T00:47:39Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)false
dc.title.none.fl_str_mv Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte
title Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte
spellingShingle Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte
Medeiros, Amira Rose Costa
Insegurança alimentar
Estudo Coorte
Food insecurity
Acquired Immune Deficiency Syndrome - AIDS
Cohort Study
CIENCIAS DA SAUDE::SAUDE COLETIVA
title_short Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte
title_full Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte
title_fullStr Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte
title_full_unstemmed Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte
title_sort Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte
author Medeiros, Amira Rose Costa
author_facet Medeiros, Amira Rose Costa
author_role author
dc.contributor.none.fl_str_mv Vianna, Rodrigo Pinheiro de Toledo
http://lattes.cnpq.br/3915051035089861
Marcos de Moraes, Ronei
http://lattes.cnpq.br/7925449690046513
dc.contributor.author.fl_str_mv Medeiros, Amira Rose Costa
dc.subject.por.fl_str_mv Insegurança alimentar
Estudo Coorte
Food insecurity
Acquired Immune Deficiency Syndrome - AIDS
Cohort Study
CIENCIAS DA SAUDE::SAUDE COLETIVA
topic Insegurança alimentar
Estudo Coorte
Food insecurity
Acquired Immune Deficiency Syndrome - AIDS
Cohort Study
CIENCIAS DA SAUDE::SAUDE COLETIVA
description Food insecurity (FI) reaches 22.6% of the Brazilian population, but its prevalence and consequence in people living with HIV/Aids (PLWHA) are little known in Brazil. The consequences were studied in PLWHA, considering its effect on clinical morbidity associated with HIV/Aids, on the metabolic changes of HIV Lipodistrophic Syndrome, cardiovascular risk (CVR) and adherence to treatment. A cohort of 400 PLWHA accompanied on a reference service in the State of Paraíba, between March 2015 to May 2016, which were classified in two groups for exposure to FI, obtained by Brazilian Range of food insecurity and accompanied by a year to evaluate the outcomes. Described if the frequencies of socio-demographic variables, clinical, laboratory and the CVR; through its association with FI, using the Chi square and Mann-Whitney tests. Instrument devised to assess adherence to antiretroviral therapy (ART). Using Kaplan-Meier estimators and Nelson-Aalen to estimate survival. The Logrank test compared the curves for variable, and we used Cox regression model to estimate the risk associated with each outcome. Devised decision tree model to identify individuals with viral load (VL) detectable. The sample was characterized by most male (61.5%), race/color brown (54.8%), mean and median age of 44 years, 57.1% education; incomplete elementary school, 48.5% were retired, 32.8% with per capita incomes between 1/3 to 1/2 minimum wage in force. The average time to diagnosis was 7.8 years and use of HAART was 6.9 years. The prevalence of was 70.7% 399 of PLWHA, being higher in households with children under 18 years old, and FI afflicted 19.5 percent of these people. Moderate or severe FI (MFI/SFI) was associated with female sex, race/color; white, low education, low income per capita, being unemployed, not being adherent to HAART and have undetectable VL. There was no difference between the groups for levels of hemoglobin, hematocrit, serum proteins, glucose, lipid profile and body mass index. Individuals in MFI/SFI were more smokers, sedentary and with higher levels of ultra sensitive protein C. The CVR was classified as high 7.9, 40.7% of PLWHA and when used, respectively, the Framingham risk score and the Overall risk score, and not related to MFI/SFI. The Accession score 42 presented 63% of accuracy to detect the PLWHA with undetectable VL and 58.5 percent ranked as adherents. Poor adherence to HAART increased by 1.6 times the risk for care in the hospital, at 1.7 times the risk to introduce infectious diseases associated with HIV/Aids and immunodeficiencies in 1.9 times the risk to submit to undetectable VL after 12 months. The MFI/SFI was associated with worse survival to seek care at the hospital, introduce infectious diseases associated with HIV/Aids immunodeficiency and have CD4 count less than 350 cells/mm3, during the following 12 months. Individuals adhering to treatment in food safety or FI take had better survival for present undetectable VL. Being in MFI/SFI increased by 1.7 times the risk to seek care at the hospital, 1.9 times the risk for infectious disease associated with HIV/Aids immunodeficiency and 1.7 times the risk for HIV/Aids related diseases not associated with immunodeficiency, during the following 12 months. At the end of this period the VL was undetectable in 76.7 percent of 322 individuals, each with their own new tests. The evaluation of VL, CD4 cell count and treatment adherence was able to predict correctly 80.0% of PLWHA regarding detectable after 12 months VL from rules obtained by the decision tree model. The FI is a stressor that worsens the clinical evolution of PLWHA in the following 12 months, such as vulnerability to be better investigated and valued for the effective control of the Aids epidemic.
publishDate 2017
dc.date.none.fl_str_mv 2017-06-16T13:14:49Z
2017-02-16
2018-07-21T00:21:57Z
2018-07-21T00:21:57Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv MEDEIROS, Amira Rose Costa. Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte. 2017. 261 f. Tese (Doutorado em Modelos de Decisão e Saúde) - Universidade Federal da Paraíba, João Pessoa, 2017
https://repositorio.ufpb.br/jspui/handle/tede/8998
identifier_str_mv MEDEIROS, Amira Rose Costa. Consequências clínicas e metabólicas da insegurança alimentar familiar em pessoas vivendo com HIV/AIDS: um estudo coorte. 2017. 261 f. Tese (Doutorado em Modelos de Decisão e Saúde) - Universidade Federal da Paraíba, João Pessoa, 2017
url https://repositorio.ufpb.br/jspui/handle/tede/8998
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal da Paraíba
Brasil
Ciências Exatas e da Saúde
Programa de Pós-Graduação em Modelos de Decisão e Saúde
UFPB
publisher.none.fl_str_mv Universidade Federal da Paraíba
Brasil
Ciências Exatas e da Saúde
Programa de Pós-Graduação em Modelos de Decisão e Saúde
UFPB
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UFPB
instname:Universidade Federal da Paraíba (UFPB)
instacron:UFPB
instname_str Universidade Federal da Paraíba (UFPB)
instacron_str UFPB
institution UFPB
reponame_str Biblioteca Digital de Teses e Dissertações da UFPB
collection Biblioteca Digital de Teses e Dissertações da UFPB
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)
repository.mail.fl_str_mv diretoria@ufpb.br|| diretoria@ufpb.br
_version_ 1801842912823083008